Hébuterne X, Filippi J, Al-Jaouni R, Schneider S
Centre Hospitalier Universitaire de Nice, Pôle Digestif, Service de Gastro-entérologie et Nutrition Clinique, Hôpital de l'Archet 2, CHU de Nice, 06202 Nice cedex 03, France.
Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S235-44. doi: 10.1016/S0399-8320(09)73159-8.
75% of hospital patients with Crohn's disease (CD) suffer from malnutrition and one third of CD patients have a body mass index below 20. Inflammatory bowel diseases (IBD) patients have many vitamin and nutrient deficiencies which can lead to important consequences such as hyperhomocysteinemia which is associated with a higher risk of thromboembolic disease. Nutritional deficiencies in IBD patients are the result of insufficient intake, malabsorption and protein-losing enteropathy as well as the metabolic distubances directly induced by the chronic disease and its treatments, in particular corticosteroids. Screening for nutritional deficiencies in chronic disease patients is warranted. Managing the deficiencies involves simple nutritional guidelines, vitamin supplements, and nutritional support in the worst cases, in particular in children in order to limit the impact of IBD on growth. In active CD, enteral nutrition is the first line therapy in children and should be used as sole therapy in adults mainly when treatment with corticosteroids is not feasible.
75%的克罗恩病(CD)住院患者存在营养不良,三分之一的CD患者体重指数低于20。炎症性肠病(IBD)患者存在多种维生素和营养素缺乏,这可能导致诸如高同型半胱氨酸血症等重要后果,而高同型半胱氨酸血症与血栓栓塞性疾病风险增加相关。IBD患者的营养缺乏是摄入不足、吸收不良、蛋白丢失性肠病以及慢性病及其治疗(尤其是皮质类固醇)直接引起的代谢紊乱所致。对慢性病患者进行营养缺乏筛查是有必要的。处理这些缺乏情况涉及简单的营养指导、维生素补充剂,在最严重的情况下,尤其是儿童,还需要营养支持,以限制IBD对生长的影响。在活动期CD中,肠内营养是儿童的一线治疗方法,在成人中主要是在皮质类固醇治疗不可行时应作为唯一治疗方法使用。